trending Market Intelligence /marketintelligence/en/news-insights/trending/VTrcc4yi4R-JaGOdzIAmeA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

AusCann appoints interim CEO


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

AusCann appoints interim CEO

AusCann Group Holdings Ltd tapped Executive Director Paul MacLeman as interim CEO of the company, effective Jan. 1, 2019.

MacLeman will hold the position until the company finds a permanent replacement for Elaine Darby, who previously announced plans to step down as AusCann's managing director.

AusCann is an Australian pharmaceutical company focused on developing cannabinoid medicines.